Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab

Summary

A one year study assessing the efficacy and safety of secukinumab compared with placebo in adult patients with moderate to severe palmoplantar pustular psoriasis - amended with an optional extension treatment period of up to a total of 148 weeks

Timeline

Start

2013-12-26

Primary completion

2014-11-24

Completion

2017-05-31

Drugs

Indications